Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China · Delayed Price · Currency is CNY 18.54
-0.28 (-1.49%)
Apr 9, 2026, 3:00 PM CST
SHA:600079 Revenue
In the year 2025, Humanwell Healthcare (Group) had annual revenue of 23.96B CNY, down -5.79%. Humanwell Healthcare (Group) had revenue of 6.08B in the quarter ending December 31, 2025, a decrease of -3.39%.
Revenue
23.96B
Revenue Growth
-5.79%
P/S Ratio
1.26
Revenue / Employee
1.36M
Employees
17,650
Market Cap
30.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 23.96B | -1.47B | -5.79% |
| Dec 31, 2024 | 25.44B | 910.74M | 3.71% |
| Dec 31, 2023 | 24.52B | 2.19B | 9.79% |
| Dec 31, 2022 | 22.34B | 1.79B | 8.71% |
| Dec 31, 2021 | 20.55B | -131.18M | -0.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beijing Tongrentang | 17.26B |
| Changchun High-Tech Industry (Group) | 12.88B |
| Livzon Pharmaceutical Group | 12.02B |
| Zhejiang Huahai Pharmaceutical | 8.71B |
| Dong-E-E-Jiao | 6.70B |
| Hubei Jumpcan Pharmaceutical | 6.14B |
| Shijiazhuang Yiling Pharmaceutical | 6.01B |
| Kangmei Pharmaceutical | 5.28B |